Table 1 Tobacco cessation therapeutic goals and interventions based on the stages of change12
Stage |
Goal |
Intervention |
Precontemplation |
ask patient about his or her feelings about smoking ask about the pros and cons of smoking assist by assuring patient that you will not push him or her to stop offer patient quitting information |
|
Contemplation |
to help patient make a decision to stop smoking in the near future to help patient feel more confident |
ask about the pros and cons of smoking cessation assist by reinforcing the reasons for change and exploring new ones suggest patient cut back or stop for a day suggest a future visit and offer information |
Preparation |
to help patient prepare for change and begin to use quitting skills |
ask about concerns, preparations and lessons learned from previous attempts advise by identifying barriers to stopping and eliciting solutions assist by providing material (booklet) and help regarding action plan, date for quitting and nicotine replacement therapy (NRT) |
Action |
to help patients stay off tobacco products and recover from slips and relapse |
ask how patient is doing (relapses, temptations, successes, NRT use) advise (relapse prevention, weight gain, triggers, etc.) assist by focusing on successes; encourage self-rewards and increased support; elicit solutions to problems |
NRT NRT formulation in Canada chewing pieces: 2 mg, 4 mg transdermal patches: 7 mg, 14 mg and 21 mg |
reduces withdrawal symptoms reduces smoking urge by sustaining tolerance (however, even a puff can lead to relapse) may maintain mood, attentiveness and stress handling (where these are affected as part of withdrawal) |
stop smoking substitute chewing piece for cigarette chew slowly use several pieces per day (depending on severity of addiction) stay on therapy for sufficient time plan staged reduction stop using |
stop smoking apply to non-hairy, clean, dry, intact skin on arm or torso remove old patch and apply new patch according to directions choose new site each time use for approximately 3 months |
Adjunctive Pharmacotherapy17 inhibits dopamine re-uptake and alters norepinephrine activity has more effect (for smoking cessation) than placebo (up to 52 weeks) reduces weight gain has minimal side effects |
Considerations
bupropion hydrochloride is an anti-depressant approved for use in tobacco cessation treatment by Health Canada it should not be used in patients with seizure disorders or with prior diagnosis of bulimia or anorexia nervosa its use is contraindicated in patients taking other anti-depressants and monoamine oxidase inhibitors patients who are allergic to
bupropion hydrochloride can be prescribed Clonidine16 |
Table 3 Suggestions for the clinical use of pharmacotherapies for smoking cessation16
Pharmacotherapy |
Precautions/ Contraindications |
Adverse Effects |
Dosage |
Duration |
Availability |
|
Local skin reaction |
21 mg/24 hr 14 mg/24 hr 7 mg/24 hr |
4 weeks then 2 weeks then 2 weeks |
Prescription and over the counter |
|
Nicotine gum |
|
Mouth soreness Dyspepsia |
1-24 cigarettes/day: 2 mg gum up to 24 pieces/day > 25 cigarettes/day: 4 mg gum up to 24 pieces/day |
Up to 12 weeks |
Over the counter |
Sustained releasea bupropion hydrochloride |
History of seizure History of eating disorder |
Insomnia Dry mouth |
150 mg every morning for 3 days then 150 mg twice daily (begin treatment 1-2 weeks prior) |
7-12 weeks maintenance up to 6 months |
Prescription |
Clonidineb |
Dry mouth Drowsiness Dizziness Sedation |
0.15-0.75 mg/day |
3-10 weeks |
Prescription |
Modified from JAMA16
a The patients
physician must conduct a physical examination and complete the patients
medical history
b If
bupropion hydrochloride is contraindicated
Table 4 Facts about the use of pharmacotherapy for smoking cessation18